CDC Finds ‘Likely’ Link between Heart Inflammation and Pfizer, Moderna COVID Vaccines • Protecting Children’s Health

Defender experienced censorship on many social channels. Be sure to keep in touch with news that matters subscribe to our top news of the day. It’s free.

The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) said Wednesday there was a “likely association“In“ mild ”inflammation of the heart in adolescents and young adults after vaccination with an mRNA COVID vaccine and a warning statement is required.

Agreed to a report through the COVID-19 Vaccine Safety Technical (VaST) Work Group, the risk of myocarditis or pericarditis after vaccination of mRNA-based outbreaks in adolescents and young adults was significantly higher after the second dose and in men.

“The presentation of clinical cases of myocarditis after vaccination is different, usually occurring within a week after post -vaccination, with chest pain being the most common presentation,” said Dr. Grace Lee, co-chair of VaST.

There is more to 1,200 cases of myocarditis or pericarditis of 16- to 24-year-olds who received a COVID mRNA vaccine, according to a series of slide presentations published Wednesday at the ACIP meeting.

Myocarditis is inflammation of the heart muscle that can lead to cardiac arrhythmia and death. According to researchers according to the National Organization for Rare Disorders, myocarditis can be the result of infections, but “myocarditis is usually the result of the body’s immune reaction to initial heart damage.”

Pericarditis is often used instead with myocarditis and refers to inflammation of the pericardium, the thin sac that surrounds the heart.

According to the CDC, men under 30 make up the majority of cases and most cases seem mild. Of the 295 people who improved the condition and were discharged, 79% were completely cured, according to the presentation. Nine people were hospitalized, with two in intensive care until June 11, according to the CDC.

The agency said that until June 11 there will be 267 cases of myocarditis or pericarditis reported after receiving one dose of mRNA vaccines and 827 reported cases after two doses. There were 132 additional cases in which the number of doses received was unknown.

Tom Shimabukuro, deputy director of the CDC’s Immunization Safety Office, said in a presentation that data from one of the agency’s safety monitoring systems – The Vaccine Safety Datalink (VSD) – suggests a rate of 12.6 cases per million three weeks after the second shooting of the 12- to 39-year-old.

Meryl Nass, a doctor of internal medicine, pointed out several errors in the data used in the ACIP presentation:

“As of now, there are two main ways to reduce the rate of myocarditis [during the presentation] are lump lump people from the age of 39 and below –– even if the highest price [of myocarditis] are in the youngest children. This water reduces the rate. The other method is to include only a very narrow window of time after vaccination is started in the 12-15 age group, thus eliminating most of the second doses, which is when the 75% or more of myocarditis cases. Likewise, genders are sometimes mixed. And rates for girls are lower than for boys. ”

During the presentations, Drs. Megan Wallance is the overall effectiveness of Pfizer’s COVID vaccine in the 12 to 15 age group 100% and Moderna’s are comparable. Wallace then performed a risk / benefit analysis comparing cases of myocarditis versus hospitalization rates for COVID in people aged 12 and 29.

“The problem with his analysis is that now the used myocarditis rate is very low. But the danger comes COVID raised, ”Nass said.

Nass further questioned why ACIP did not include the nearly 6,000 who died. reports of the Vaccine Adverse Events Reporting System (VAERS) of the risk pool when determining risk and benefits.

During the presentation, a CDC spokesman said vaccine considerations for people with a history of myocarditis and pericarditis would be updated:

  • People with a history of pericarditis are encouraged to receive any COVID vaccine approved by the FDA.
  • Anyone with a history of myocarditis is encouraged to receive an FDA -approved COVID vaccine once their heart has healed.
  • People with a history of myocarditis after the first dose of an mRNA vaccine are encouraged to skip the second dose until more information is available, but if the heart has healed, a second dose may be considered.

CDC officials say they are gathering a lot of data to fully understand the potential risks, how to manage them and if there are any long -term issues.

Officials stressed the benefits of vaccines outweigh the risks, and cited the fact that for every million doses of mRNA vaccine given, more cases of COVID and hospitalization are prevented. compared with the number of potential myocarditis cases.

Public commentators criticize CDC for overstated COVID risks for children

Public commentators – during public comment session -chastised the CDC and the advisory committee for adopting the principle that the benefits of the experimental vaccine COVID outweigh the risks to adolescents, when adolescents have a lower risk of die of COVID, and are at the shortest risk experienced bad events.

Approved by CDC, COVID youth cost of hospitalization in the 12-17 age group was 2.1 per 100,000 in early January 2021, and 1.3 per 100,000 in April. Of the 204 hospitalizations reviewed by the CDC from March 1, 2020 to April 24, 2021, no deaths occurred.

Agreed to CDC data, the mortality rate among young people aged 0 to 17 who got COVID and after hospitalization 0.7%, with many experienced at least a little or no symptoms of all. COVID mortality rate in all age categories of young people less than 0.1%, according to the CDC.

Two roles published May 19 in the journal Hospital Pediatrics found the child hospitalizations for COVID exceeded by at least 40%, carrying potential implications for the national figures used to justify vaccination of children.

Another study, referred to by a public commentator, has shown in many cases that diagnosing COVID within the underlying reason the patient was hospitalized-means that there is no documentation of COVID symptoms prior to -Hospital.

the first public commentator SAYS [time stamp: 3:38]:

“As of June 11, looking at myocarditis and pericarditis only, there were 197 reports of children aged 30-39 years, 392 reports of children aged 19-29 and 279 reports of 18 years. up.Looking at Harvard Pilgrim Study stating that less than 1% of adverse events were reported by VAERS, it is reasonable to assume that these numbers are much higher than reported. From the meeting here today, we have heard that there have been over 1,200 cases of myocarditis and pericarditis, mostly people under 30 years of age. It should sound the alarm for all of you. It really is for me. ”

William Houston, with a public research organization focused on public health and safety, said in public comment the CDC withheld VAERS data and delayed the publication of negative reports on the incident. The actual numbers, Houston estimates, are 3 to 14 times higher than what the public has done to date.

This is consistent with many stories of myocarditis in adolescents recently covered with The Protector – all who report to VAERS and are given ID numbers, but not yet published in the VAERS database.

Another public comment [time stamp 3:56:28], a parent and parenting advocate, expressed concern that ACIP members were instructed to vote at a previous meeting, even if the data was not yet available. He also questioned why different reporting systems use different age group members.

He lashed out at the committee’s cancellation of the emergency meeting on heart inflammation scheduled for June 8 and said that in December, ACIP met several times over the weekend when manufacturers wanted their vaccine approval. .

Public commentator [time stamp 3:59] Leslie Moore, doctor and mother, said the COVID vaccine data is alarming and frightening. Moore said vaccines are still being tested and there is no comprehensive monitoring and data collection.

“People are shot and left to face the consequences on their own,” Moore said.

Moore continues:

“We only have the VAERS system, which is voluntary self-reporting. We know that VAERS only accounts for 1-10% of all adverse events. Adverse events are severely unreported for a variety of reasons. .I watched VAERS open this morning.These products have accumulated 6,000 deaths and 20,000 hospitalized in the U.S., alone –– more than the other 70 vaccines in the past 30 years combined. that’s with severe under-reporting and a two-month backlog.Face it, these vaccines are not safe.

“Now let’s think about these products for children. What is the risk benefit analysis? Children are at an insignificant risk from COVID-19, so there is no benefit to vaccination, and not you can vaccinate them to benefit others.These shots don’t work that way.They can’t prevent infection or transmission.Your shot, at best, protects you from severe symptoms, nothing else.

“Kids have no benefit, just risk from these products. Any child injured or killed by the shot can recover from the virus and receive extensive and lasting natural resistance. ”

The body’s natural strength is always better than vaccine resistance – anyone who says they have to go back to medical school, Moore told committee members.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *